| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Stages | Seed, Startup, Early Stage, Expansion, Later Stage |
| Investing | United States |
| Investment Range | $250,000 - $10,000,000 |
| Assets Under Management | $100,000,000 |
Brightstone Venture Capital is a Minneapolis-based venture capital fund that manages $100 million in assets, targeting early-growth stage investment opportunities. They focus on leveraging the deep operating experience and successful investment backgrounds of the fund's partners, with a core emphasis on a variety of promising sectors.
These sectors include Technology, which covers Data Storage and Management, Virtual/Augmented Reality, AI/Machine Learning, Enterprise Security, Blockchain, Cloud Infrastructure, and Marketplaces. The Life Sciences sector is another area of concentration, involving Regenerative Medicine, Stem Cell research, Next-Gen Diagnostics, Genomics/Gene Editing, Medical Devices, Drug Discovery Tools, and Platforms, as well as Personalized Medicine.
Brightstone is known for their expertise in equity investments with a minimum investment threshold of $250,000 and can invest up to $10 million. The fund specializes in Seed, Startup, Early Stage, Expansion, and Later Stage funding, aiming to help extraordinary entrepreneurs build exceptional companies.
The team comprises experienced professionals with diverse backgrounds in venture investment, investment banking, and operational management across industries such as Information Technology, Life Sciences, Consumer Products, Fin-Tech, and Cyber Security. Advisors in the fund bring expertise from IT/Cloud, Healthcare, EAS/SaaS, Dermatology, AI/ML, MedTech, and UX/UI to support the portfolio companies.
Brightstone’s current portfolio showcases a range of innovative companies across Technology and Life Sciences, many of which have secured significant funding rounds or successful exits, underlining the fund's commitment to extraordinary growth, vision, scale, technology, and connections.









